Abstracts tagged "Early Rheumatoid Arthritis and ultrasonography"

Abstract Number: 905 • 2014 ACR/ARHP Annual Meeting
First Step in the Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis: A Data Driven Approach
Anna-Birgitte Aga¹, Hilde Berner Hammer², Inge C. Olsen¹, Till Uhlig², Tore K. Kvien³, Désirée van der Heijde⁴, Elisabeth Lie³, Espen A. Haavardsholm⁵ and the Arctic study Group⁵, ¹Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Postboks 23 Vinderen, Diakonhjemmet Hospital, Oslo, Norway, ³Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁵Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose The use of ultrasonography (US) in rheumatoid arthritis (RA) is rapidly increasing. Currently, there is no consensus regarding which joints and tendons should be…
Abstract Number: L9 • 2014 ACR/ARHP Annual Meeting
Contrast Enhanced Ultrasonography in Patients Diagnosed with Early Arthritis: A Preliminary Experience
Maria-Magdalena Tamas¹, Nicolae Rednic², Ana Petcu¹, Cosmina Ioana Bondor³, Horatiu Popoviciu⁴, Eugenia Mociran⁵ and Simona Rednic¹, ¹Department of Rheumatology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania, ²4th Medical Clinic Cluj-Napoca, Cluj-Napoca, Romania, ³Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania, ⁴Rheumatology, University of Medicine and Pharmacy Targu Mures, Tg Mures, Romania, ⁵Rheumatology, Policlinica "Sf. Ioan" Baia Mare, Baia Mare, Romania
Background/Purpose: The role of ultrasonography (US) in early rheumatoid arthritis (ERA) for detecting synovial hypertrophy and its vascularity has already been demonstrated. Contrast enhanced ultrasonography…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].